Skip to main content
Premium Trial:

Request an Annual Quote

Provista Dx Raises $3.9M

NEW YORK (GenomeWeb) – Proteomics-based diagnostics firm Provista Diagnostics has raised $3.9 million, it said in a regulatory document filed on Monday. 

The Scottsdale, Ariz.-based firm did not respond to requests for comment. In a document filed with the US Securities and Exchange Commission, Provista said that there were 24 investors in the private offering of equity. It did not say how the funds would be used. 

Provista develops blood-based tests for the diagnosis, prognosis, and monitoring of breast and gynecological cancer patients. In April 2014, it said that it completed a Series B financing round that raised $6 million to fund two prospective clinical trials to evaluate Provista's dtectDx-Breast test. The test is aimed at aiding physicians in determining whether or not to pass patients with suspicious lesions on for a biopsy.

Recently, the company presented data from its studies at the 2015 Miami Breast Cancer Conference suggesting that its combinatorial biomarker panel "is useful in informing the decision to biopsy or continue with six-month follow up," Provista CEO David Reese said in a statement. 

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.